Abstract
THIS ARTICLE HAS BEEN RETRACTED
Current Drug Targets - Inflammation & Allergy
Title:Retraction Notice: Emerging Targets for COPD Therapy
Volume: 4 Issue: 6
Author(s): Peter J. Barnes
Affiliation:
Abstract: THIS ARTICLE HAS BEEN RETRACTED
Export Options
About this article
Cite this article as:
Barnes J. Peter, Retraction Notice: Emerging Targets for COPD Therapy, Current Drug Targets - Inflammation & Allergy 2005; 4 (6) . https://dx.doi.org/10.2174/156801005774912833
DOI https://dx.doi.org/10.2174/156801005774912833 |
Print ISSN 1568-010X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-010X |
Related Journals
Related Books
8
Related Articles
-
Therapeutic Neovascularization by the Implantation of Autologous Mononuclear Cells in Patients with Connective Tissue Diseases
Current Pharmaceutical Design Protective Role of Italian Juglans regia L. nut Ethanolic Extract in Human Keratinocytes under Oxidative and Inflammatory Stress
Current Pharmaceutical Biotechnology Psychosocial Implications During Adolescence for Infant Heart Transplant Recipients
Current Cardiology Reviews Correlation of Waist to Calf Circumference Ratio and Carotid Intima-Media Thickness in Diabetes Mellitus
Current Diabetes Reviews Effectors of Fatty Acid Oxidation Reduction: Promising New Anti-Ischaemic Agents
Current Pharmaceutical Design The Impact of Uncontrolled Hypertension on the Longitudinal Systolic Function of the Left Ventricle
Current Hypertension Reviews Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders
Current Drug Metabolism Non-Vitamin K Oral Anticoagulants (NOACs) A Review of Clinical Management and Laboratory Issues
Current Vascular Pharmacology Stem Cell Therapy for the Treatment of Myocardial Infarction
Current Pharmaceutical Design Effects of Olive Oil on TNF-α and IL-6 in Humans: Implication in Obesity and Frailty
Endocrine, Metabolic & Immune Disorders - Drug Targets Resveratrol and Neurodegenerative Diseases: Activation of SIRT1 as the Potential Pathway towards Neuroprotection
Current Neurovascular Research Characterization of Supraventricular Tachycardia in Infants: Clinical and Instrumental Diagnosis
Current Pharmaceutical Design Meet our Editorial Board Member
Cardiovascular & Hematological Agents in Medicinal Chemistry Cell Microencapsulation Implants into the Central Nervous System
Recent Patents on Nanomedicine From Diabetes to Metabolic Syndrome: A View Point on An Evolving Concept
Current Pharmaceutical Design Green Synthesis of Novel Phthalimide Derivatives of Aspirin and P-aminosalicylic Acid as Potential Analgesic- antipyretic and Anti-tuberculosis Agents
Letters in Organic Chemistry Xanthine Oxidase and its Role as Target in Cardiovascular Disease: Cardiovascular Protection by Enzyme Inhibition?
Current Pharmaceutical Design Gauging Reactive Metabolites in Drug-Induced Toxicity
Current Medicinal Chemistry Pharmacologic Therapy for Cardiovascular Risk Reduction in Patients with the Metabolic Syndrome
Current Pharmaceutical Design Lone Atrial Fibrillation- A Diagnosis of Exclusion
Current Pharmaceutical Design